Overview and Scope
Coronary artery disease (CAD) is a medical condition that affects the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Coronary artery disease occurs when arteries become narrowed or blocked due to plaque buildup, a substance composed of cholesterol, fat, calcium, and other substances.
Sizing and Forecast
The coronary artery disease market size has grown rapidly in recent years. It will grow from $26.3 billion in 2023 to $28.97 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to prevalence of coronary artery disease, growth in minimally invasive surgeries, increase in sedentary lifestyles, aging population and cad prevalence, evolution of pharmacological treatments..
The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $42.65 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing lifestyle factors, focus on telemedicine and remote monitoring, expansion of interventional cardiology procedures, shift towards value-based healthcare models, development of novel drug therapies.. Major trends in the forecast period include development of gene therapies, integration of artificial intelligence in diagnosis, focus on mental health in cad care, rise in home-based healthcare services, adoption of remote cardiac rehabilitation..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report
Segmentation & Regional Insights
The coronary artery disease market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
North America was the largest region in the coronary artery disease market in 2023. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of coronary artery disease is expected to propel the growth of the coronary artery disease market over the coming years. Coronary artery disease (CAD) is a medical condition characterized by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. Coronary artery disease cases are increasing due to increased changes in diet, stress, lack of exercise, obesity, age, and others. Coronary artery disease is treated with drugs using clopidogrel, ticagrelor, warfarin, and heparin and with procedures such as coronary artery bypass grafting, angioplasty, and stenting. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, coronary heart disease, the most prevalent form of heart disease, claimed the lives of 375,476 individuals. Approximately 5% of adults aged 20 and above are affected by coronary artery disease (CAD), translating to about 1 in 20 individuals. Therefore, the rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease market during the forecast period.
Key Industry Players
Major companies operating in the coronary artery disease market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.
The coronary artery disease market report table of contents includes:
1. Executive Summary
2. Coronary Artery Disease Market Characteristics
3. Coronary Artery Disease Market Trends And Strategies
4. Coronary Artery Disease Market – Macro Economic Scenario
5. Global Coronary Artery Disease Market Size and Growth
….
32. Global Coronary Artery Disease Market Competitive Benchmarking
33. Global Coronary Artery Disease Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Coronary Artery Disease Market
35. Coronary Artery Disease Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
